| Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease. | Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.
Cetinsoy O, Anyanwu I, Krishnanand H, Natarajan G, Ramachandran N, Thomas A, Brookes KJ. | 05/7/2024 |
| uPAR (PLAUR) Marks Two Intra-Tumoral Subtypes of Glioblastoma: Insights from Single-Cell RNA Sequencing. | uPAR (PLAUR) Marks Two Intra-Tumoral Subtypes of Glioblastoma: Insights from Single-Cell RNA Sequencing.
He Y, Døssing KBV, Rossing M, Bagger FO, Kjaer A., Free PMC Article | 03/8/2024 |
| Circulating miR-10b, soluble urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response. | Circulating miR-10b, soluble urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response.
Setiawan L, Setiabudy R, Kresno SB, Sutandyo N, Syahruddin E, Jovianti F, Nadliroh S, Mubarika S, Setiabudy R, Siregar NC., Free PMC Article | 03/4/2024 |
| Soluble urokinase plasminogen activator receptor (suPAR) in bronchoalveolar fluid and blood in critically ill patients-a prospective cohort study. | Soluble urokinase plasminogen activator receptor (suPAR) in bronchoalveolar fluid and blood in critically ill patients-a prospective cohort study.
Reisinger AC, Hatzl S, Prattes J, Hackl G, Schilcher G, Eisner F, Niedrist T, Raggam R, Krause R, Eller P., Free PMC Article | 02/14/2024 |
| Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis. | Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis.
Rotbain Curovic V, Tavenier J, Ferreira-Divino LF, Poulsen CG, Houlind MB, Pedersen OB, Urbak L, Hansen TW, Sillesen H, Frimodt-Møller M, Hvas AM, Rossing P. | 01/27/2024 |
| Soluble urokinase plasminogen activator receptor in vaginally collected amniotic fluid predicting fetal inflammatory response syndrome: a prospective cohort study. | Soluble urokinase plasminogen activator receptor in vaginally collected amniotic fluid predicting fetal inflammatory response syndrome: a prospective cohort study.
Gulbiniene V, Dumalakiene I, Balciuniene G, Pilypiene I, Narkeviciute I, Novickij V, Vysniauskis G, Ramasauskaite D., Free PMC Article | 01/16/2024 |
| A case of mosaic deletion of paternally-inherited PLAGL1 and two cases of upd(6)mat add to evidence for PLAGL1 under-expression as a cause of growth restriction. | A case of mosaic deletion of paternally-inherited PLAGL1 and two cases of upd(6)mat add to evidence for PLAGL1 under-expression as a cause of growth restriction.
Alhendi ASN, Gazdagh G, Lim D, McMullan D, Wright M, Temple IK, Davies JH, Mackay DJG. | 01/12/2024 |
| Enhancing the invasive traits of breast cancers by CYP1B1 via regulation of p53 to promote uPAR expression. | Enhancing the invasive traits of breast cancers by CYP1B1 via regulation of p53 to promote uPAR expression.
Kwon YJ, Kwon TU, Shin S, Lee B, Lee H, Park H, Kim D, Moon A, Chun YJ. | 11/16/2023 |
| Plasma IL-6, TREM1, uPAR, and IL6/IL8 biomarkers increment further witnessing the chronic inflammation in type 2 diabetes. | Plasma IL-6, TREM1, uPAR, and IL6/IL8 biomarkers increment further witnessing the chronic inflammation in type 2 diabetes.
Sater MS, AlDehaini DMB, Malalla ZHA, Ali ME, Giha HA. | 10/11/2023 |
| SuPAR mediates viral response proteinuria by rapidly changing podocyte function. | SuPAR mediates viral response proteinuria by rapidly changing podocyte function.
Wei C, Datta PK, Siegerist F, Li J, Yashwanth S, Koh KH, Kriho NW, Ismail A, Luo S, Fischer T, Amber KT, Cimbaluk D, Landay A, Endlich N, Rappaport J, Michigan Medicine COVID−19 Investigators, Hayek SS, Reiser J., Free PMC Article | 09/8/2023 |
| YY1 regulates the proliferation and invasion of triple-negative breast cancer via activating PLAUR. | YY1 regulates the proliferation and invasion of triple-negative breast cancer via activating PLAUR.
Zhang C, Chen S, Wang W, Gao Y. | 08/9/2023 |
| Recent Advances in Targeting the Urokinase Plasminogen Activator with Nanotherapeutics. | Recent Advances in Targeting the Urokinase Plasminogen Activator with Nanotherapeutics.
Kumar AA, Vine KL, Ranson M. | 06/15/2023 |
| PLAUR splicing pattern in hereditary angioedema patients' monocytes and macrophages. | PLAUR splicing pattern in hereditary angioedema patients' monocytes and macrophages.
Ballonová L, Kulíšková P, Slanina P, Štíchová J, Vlková M, Hakl R, Litzman J, Souček P, Freiberger T. | 05/30/2023 |
| Comprehensive analysis of the diagnostic and therapeutic value of the hypoxia-related gene PLAUR in the progression of atherosclerosis. | Comprehensive analysis of the diagnostic and therapeutic value of the hypoxia-related gene PLAUR in the progression of atherosclerosis.
Dai C, Lin Y., Free PMC Article | 05/30/2023 |
| Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis. | Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis.
Abdellatif HAA, Sultan BO, Nassar HM, Gomaa MEE, Sakr MG, Riad E, Al-Harbi AI, Abdulhakim JA, Fawzy MS, Abd El-Fadeal NM., Free PMC Article | 05/3/2023 |
| Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane. | Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane.
Pang H, Ouyang J, Yang Z, Shang H, Liang G., Free PMC Article | 01/21/2023 |
| Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis. | Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis.
Hindy G, Tyrrell DJ, Vasbinder A, Wei C, Presswalla F, Wang H, Blakely P, Ozel AB, Graham S, Holton GH, Dowsett J, Fahed AC, Amadi KM, Erne GK, Tekmulla A, Ismail A, Launius C, Sotoodehnia N, Pankow JS, Thørner LW, Erikstrup C, Pedersen OB, Banasik K, Brunak S, Ullum H, Eugen-Olsen J, Ostrowski SR, DBDS Consortium, Haas ME, Nielsen JB, Lotta LA, Regeneron Genetics Center, Engström G, Melander O, Orho-Melander M, Zhao L, Murthy VL, Pinsky DJ, Willer CJ, Heckbert SR, Reiser J, Goldstein DR, Desch KC, Hayek SS., Free PMC Article | 01/14/2023 |
| The Association of PLAUR Genotype and Soluble suPAR Serum Level with COVID-19-Related Lung Damage Severity. | The Association of PLAUR Genotype and Soluble suPAR Serum Level with COVID-19-Related Lung Damage Severity.
Nekrasova LA, Shmakova AA, Samokhodskaya LM, Kirillova KI, Stoyanova SS, Mershina EA, Nazarova GB, Rubina KA, Semina EV, Kamalov AA., Free PMC Article | 01/11/2023 |
| TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR. | TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR.
Zhang T, Wang B, Su F, Gu B, Xiang L, Gao L, Zheng P, Li XM, Chen H., Free PMC Article | 07/30/2022 |
| Comprehensive analysis of the importance of PLAUR in the progression and immune microenvironment of renal clear cell carcinoma. | Comprehensive analysis of the importance of PLAUR in the progression and immune microenvironment of renal clear cell carcinoma.
Wang Z, Wang K, Gao X, Liu Z, Xing Z., Free PMC Article | 06/18/2022 |
| Soluble urokinase plasminogen activator receptor: a novel biomarker of pediatric community-acquired and hospitalacquired pneumonia. | Soluble urokinase plasminogen activator receptor: a novel biomarker of pediatric community-acquired and hospitalacquired pneumonia.
El-Mekkawy MS, Soliman SE, Saleh NY. | 05/7/2022 |
| Higher Cerebrospinal Fluid Soluble Urokinase-type Plasminogen Activator Receptor, But Not Interferon gamma-inducible Protein 10, Correlate With Higher Working Memory Deficits. | Higher Cerebrospinal Fluid Soluble Urokinase-type Plasminogen Activator Receptor, But Not Interferon γ-inducible Protein 10, Correlate With Higher Working Memory Deficits.
De Almeida SM, Rotta I, Tang B, Umlauf A, Vaida F, Cherner M, Franklin D, Letendre S, Ellis RJ, HNRC Group., Free PMC Article | 04/16/2022 |
| MAGP2 induces tumor progression by enhancing uPAR-mediated cell proliferation. | MAGP2 induces tumor progression by enhancing uPAR-mediated cell proliferation.
Wu L, Zhou F, Xin W, Li L, Liu L, Yin X, Xu X, Wang Y, Hua Z. | 04/9/2022 |
| Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Black Adults. | Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Black Adults.
Olson NC, Raffield LM, Moxley AH, Miller-Fleming TW, Auer PL, Franceschini N, Ngo D, Thornton TA, Lange EM, Li Y, Nickerson DA, Zakai NA, Gerszten RE, Cox NJ, Correa A, Mohlke KL, Reiner AP., Free PMC Article | 03/19/2022 |
| Blood suPAR, Th1 and Th17 cell may serve as potential biomarkers for elderly sepsis management. | Blood suPAR, Th1 and Th17 cell may serve as potential biomarkers for elderly sepsis management.
Zhao L, Yu S, Wang L, Zhang X, Hou J, Li X. | 03/5/2022 |